AOTI, Inc. (AIM:AOTI)

London flag London · Delayed Price · Currency is GBP · Price in GBX
56.00
-2.00 (-3.45%)
May 28, 2026, 8:02 AM GMT
Market Cap62.75M -26.2%
Revenue (ttm)49.44M +14.0%
Net Income1.98M
EPS0.01
Shares Out 106.36M
PE Ratio39.70
Forward PE47.20
Dividendn/a
Ex-Dividend Daten/a
Volume709
Open59.00
Previous Close58.00
Day's Range56.00 - 59.00
52-Week Range25.00 - 99.00
Betan/a
AnalystsStrong Buy
Price Target91.00 (+62.5%)
Earnings DateMar 30, 2026

About AOTI, Inc.

AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2008
Employees 103
Stock Exchange London Stock Exchange AIM
Ticker Symbol AOTI
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

AOTI, Inc. Earnings Call Transcript: H2 2025

Revenue grew 14% to $66.5M with strong underlying growth, despite U.S. healthcare headwinds and Arizona payment delays. Awaiting CMS Medicare coverage, which could expand the addressable market 65-fold and drive future growth.

2 months ago - Transcripts

AOTI, Inc. Annual report: H2 2025

AOTI, Inc. has published its H2 2025 annual report on March 30, 2026.

2 months ago - Filings

AOTI, Inc. Slides: H2 2025

AOTI, Inc. has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 30, 2026.

2 months ago - Filings

AOTI, Inc. Earnings release: H2 2025

AOTI, Inc. released its H2 2025 earnings on February 23, 2026, summarizing the period's financial results.

3 months ago - Filings

AOTI, Inc. Earnings Call Transcript: H1 2025

Revenue grew 21% year-on-year, led by Medicaid and VA segments, despite U.S. regulatory headwinds. High gross margins and strong clinical validation support a positive outlook, with CMS approval expected to be transformational.

8 months ago - Transcripts

AOTI, Inc. Quarterly report: H1 2025

AOTI, Inc. has published its H1 2025 quarterly earnings report on September 22, 2025.

8 months ago - Filings

AOTI, Inc. Slides: H1 2025

AOTI, Inc. has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 22, 2025.

8 months ago - Filings

AOTI, Inc. Earnings release: H1 2025

AOTI, Inc. released its H1 2025 earnings on July 21, 2025, summarizing the period's financial results.

11 months ago - Filings